Faeth Therapeutics, Inc. (FTH) Insider Trading

Name: Faeth Therapeutics, Inc. (FTH) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 15, 2026): Karen H. Vousden (Director): Grant/Award of 25,000 shares.

Get alerted when insiders trade FTH

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta